BioVeda China Fund is a venture capital firm that provides financing to companies in the life science and healthcare industries, with leading proprietary technologies, and outstanding scientific and management talent. With headquarters in Shanghai and Zhangjiang Hi-tech Park Pudong New Area, BioVeda China Fund is the first international venture capital firm dedicated to identifying, financing and building future industry leaders in China and the world.

We have large blue chip international institutional and strategic corporate investors, and an Investment Management Team with both domestic and international investment experience, and strong lifescience and healthcare backgrounds and domain knowledge.  Our Scientific Advisory Board consists of prominent and internationally recognized experts from both China and the West.  BioVeda China Fund is a crucial business and scientific bridge between companies in China and the West, linking finance and technology between two very diverse markets.

Through our experienced Investment Management Team, and prestigious international Scientific Advisory Board, BioVeda China Fund has a strong combination of broad scientific, industry and medical expertise, financial and investment experience, and privileged networks in China and in the West, all of which brings tremendous added value to our investments.